ArticleMolecular therapy. Oncology2024
Mesenchymal stem cell origin contributes to the antitumor effect of oncolytic virus carriers.
Makoto Sukegawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it